BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7352569)

  • 1. Platelet MAO Vmax and Km in chronic schizophrenic subjects.
    Giller EL; Bierer L; Rubinow D; Docherty JP
    Am J Psychiatry; 1980 Jan; 137(1):97-8. PubMed ID: 7352569
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetic constants of platelet monoamine oxidase in schizophrenia.
    Jackman HL; Meltzer HY
    Am J Psychiatry; 1983 Aug; 140(8):1044-7. PubMed ID: 6869590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients.
    Domino EF; Khanna SS
    Am J Psychiatry; 1976 Mar; 133(3):323-6. PubMed ID: 943955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
    Kobes RD; Potkin SG; Wise CD; Bridge TP; Neckers LM; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):179-85. PubMed ID: 298347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous modulation of monoamine oxidase in schizophrenic and normal humans.
    Becker RE; Giambalvo CT
    Am J Psychiatry; 1982 Dec; 139(12):1567-70. PubMed ID: 7149055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet monoamine oxidase in chronic schizophrenic patients.
    Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients.
    Meltzer HY; Stahl SM
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):419-31. PubMed ID: 4594367
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet monoamine oxidase activity and genetic vulnerability to schizophrenia.
    Baron M; Levitt M; Gruen R; Kane J; Asnis L
    Am J Psychiatry; 1984 Jul; 141(7):836-42. PubMed ID: 6731631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The preliminary study of monoamine oxidase activity in platelets in patients with schizophrenia and affective disorder].
    Lin Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):325-7, 382. PubMed ID: 1304991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase (MAO) of platelets, plasma, lymphocytes and granulocytes in schizophrenia.
    Bond PA; Cundall RL; Falloon IR
    Br J Psychiatry; 1979 Apr; 134():360-5. PubMed ID: 444786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patients.
    Owen F; Bourne R; Crow TJ; Johnstone EC; Bailey AR; Hershon HI
    Arch Gen Psychiatry; 1976 Nov; 33(11):1370-3. PubMed ID: 791182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet monamine oxidase in chronic schizophrenia. Some enzyme characteristics relevant to reduced activity.
    Murphy DL; Donnelly CH; Miller L; Wyatt RJ
    Arch Gen Psychiatry; 1976 Nov; 33(11):1377-81. PubMed ID: 985048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAO activity, csf amine metabolites, and drug-free improvement in schizophrenia.
    Van Kammen DP; Marder SR; Murphy DL; Bunney WE
    Am J Psychiatry; 1978 May; 135(5):567-9. PubMed ID: 645949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The study of the platelet monoamine oxidase activity in chronic schizophrenic patients (author's transl)].
    Shohmori T; Kaneyuki T; Doi T; Mitani K; Kohsaka M
    Seishin Shinkeigaku Zasshi; 1977 Oct; 79(10):563-7. PubMed ID: 607254
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.
    Schildkraut JJ; Herzog JM; Orsulak PJ; Edelman SE; Shein HM; Frazier SH
    Am J Psychiatry; 1976 Apr; 133(4):438-40. PubMed ID: 1267046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet monoamine oxidase activity in schizophrenia: a review of the data.
    Wyatt RJ; Potkin SG; Murphy DL
    Am J Psychiatry; 1979 Apr; 136(4A):377-85. PubMed ID: 371419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population.
    Demisch L; Gebhart P; Kaczmarczyk P; von der Mühlen H; Bochnik HJ
    Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet serotonin concentration and monoamine oxidase activity in unmedicated chronic schizophrenic and in schizoaffective patients.
    Joseph MH; Owen F; Baker HF; Bourne RC
    Psychol Med; 1977 Feb; 7(1):159-62. PubMed ID: 859953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delusional misidentification and platelet monoamine oxidase.
    Barton JL; Chaparala S; Barton ES; Jackson IV; Davis LG
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.